Search Results

South Korea Advances First Domestic Commercial Production of Lu-177 Using Wolsong Heavy Water Reactors

Korea Hydro & Nuclear Power (KHNP) plans to use the heavy water reactors at the Wolsong Nuclear Power Plant to produce, for the first time domestically, the radioisotope lutetium-177 (Lu-177) for cancer treatment. Currently, South Korea relies entirely on imports for this material, which imposes cost pressures and supply instability on local radiopharmaceutical companies such as Cellbion and FutureChem. Industry experts generally believe that domestic production will help build a diversified supply chain and shorten transportation times. The primary goal of this plan is to achieve commercial production of Lu-177, with pilot production expected in 2028 and full-scale production commencing in 2031. Subsequently, KHNP will expand production to include cobalt...

2026-08-06

Czech nuclear safety officials say domestic nuclear power plants have sufficient cooling water for both existing and new units

Droughts across parts of Europe are affecting the operation of some nuclear power plants. Due to low water levels and flow rates in the Danube River, two reactors at Romania's Cernavodă Nuclear Power Plant have been shut down, and Hungary's Paks Nuclear Power Plant also faces the risk of a complete shutdown. Štěpán Kochánek, Chairman of the Czech State Office for Nuclear Safety (SÚJB), stated that plant operators should not be allowed to continue operating units at full power when cooling water is insufficient, and that related shutdown measures are conservative actions predefined in operating procedures. Kochánek explained that reactor shutdowns are not an unusually rare operation. Unit shutdown typically involves gradually reducing reactor power, inserting control rods, and bringing fission reactions to a minimal level or complete cessation. After shutdown, the reactor still requires cooling, but the demand for cooling water volume and capacity is significantly lower than during full-power operation. He noted that this process shares similarities with planned outages such as refueling overhauls and is a standardized procedure that operators should master.

2026-08-05

Zhang Yiming, Chairman of HTA: Tackling the "Last Mile" of Nuclear Pharmacy Network Delivery to Bring Domestic Radiopharmaceuticals to Patients in Western and County-Level Regions

On July 28, the 2026 Radiopharmaceutical Innovation and Development Conference was held in Taiyuan, Shanxi Province. Zhang Yiming, Party Committee Secretary and Chairman of HTA, told reporters that the company is restructuring its short half-life radiopharmaceutical delivery system through "regional layout + standardized logistics + grassroots empowerment," striving to ensure that cancer patients in western and county-level regions can access domestically produced radiopharmaceuticals within the drug's effective half-life window. Currently, multi-dimensional policy dividends are being continuously released, and China's radiopharmaceutical industry is entering a critical window of opportunity. Alpha nuclide drugs represent the future direction of therapeutic radiopharmaceuticals. Zhang Yiming introduced that HTA has already made early arrangements for drug research in this field, jointly conducting research on actinium-225 labeled...

2026-08-05

Russia Plans to Complete Domestic MRI Scanner Development by 2027

On August 1, Russian Prime Minister Mikhail Mishustin stated that Russia should complete the development of a domestically produced MRI scanner by 2027. Mishustin learned about the relevant progress during his visit to the Consultative Diagnostic Center in the Republic of Tyva. While inspecting the MRI equipment installed at the center, he asked Russian Health Minister Mikhail Murashko about the development of domestic devices. Murashko stated that the research and development work is being carried out by Rosatom, and noted that the device is expected to be completed next year. Mishustin then expressed hope that Russia would have its own domestically developed MRI scanner next year. If the device is completed as planned, it will be used in the field of medical imaging diagnostics.

2026-08-05

Xinjiang's First Domestically Developed SPECT/CT Put into Operation at the First Affiliated Hospital of Shihezi University

Recently, the mid-term summary meeting of the National Key R&D Program project "Research on Application Solutions for Domestically Developed Dual-Head Single-Photon Imaging Equipment (SPECT)" under the 14th Five-Year Plan, along with the SPECT/CT commissioning ceremony and academic seminar, was held at the First Affiliated Hospital of Shihezi University. The Insight four-dimensional quantitative SPECT/CT from永新医疗 (Yongxin Medical) was officially installed in Xinjiang, becoming the first domestically developed SPECT/CT system put into clinical use in the region. A representative from the First Affiliated Hospital of Shihezi University stated that the commissioning of the domestically developed SPECT/CT will help the hospital improve its precision diagnosis and treatment system in northern Xinjiang and enhance regional nuclear medicine service capabilities. Experts attending the meeting noted that the deployment of this system in clinical practice will help explore the standardized application pathways of SPECT/CT in primary hospitals and accumulate clinical experience in the use of nuclear medicine imaging equipment in western China.

2026-08-03

Beijing Key Laboratory Unveiled: Focusing on Domestic Production of Liquid-Helium-Free Superconducting MRI and X-ray CT Equipment

Recently, the "Beijing Key Laboratory for Innovation and Translation of Advanced Superconducting MRI and CT Medical Equipment," spearheaded by Wandong Medical, was officially inaugurated. Previously approved by the Beijing Municipal Science &

2026-07-27